gip1 vs glp 1 Gastrointestinal Incretins—Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) beyond Pleiotropic Physiological Effects Are Involved in Pathophysiology of Atherosclerosis and Coronary Artery Disease—State of the Art Do Fasting GLP-1 and GIP

Rare but Serious Risks Gastroparesis (delayed stomach emptying) Intestinal blockage Pancreatitis For people with UC who have had surgeries, these risks may mean you need extra caution and closer monitoring As with any medication, understanding the risks is especially important when you have UC, particularly for people with a history of strictures, surgery, or complex disease, Moss says

Jul 1997;273(1 Pt 1):E185-191

Sources: Pfaus JG, et al

This is the same mechanism targeted by topical brightening agents, delivered systemically instead, and the effect is best understood as a gradual, cumulative brightening support across a series rather than an overnight change

Oral formulations are mainly discussed for gastrointestinal applications, but research remains limited